CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 50,000 shares at $6.38 ($319,000)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Strategy Officer acquired 85,821 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 13,176 shares at an average $3.32 ($43,807)
- 4 Open-market sale Senior VP, Finance and PAO sold 7,842 shares at an average $3.32 ($26,072)
- 4 Open-market sale President, CEO and CFO sold 17,566 shares at an average $3.32 ($58,402)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President, CEO and CFO bought 125 shares at $4.61 ($576)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Senior VP, Finance and PAO bought 125 shares at $4.61 ($576)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 8 · 142 filings